EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 241 filers reported holding EDITAS MEDICINE INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $493,000 | -44.3% | 41,687 | -10.5% | 0.00% | -20.0% |
| Q1 2022 | $885,000 | -48.6% | 46,562 | -24.7% | 0.01% | -44.4% |
| Q4 2021 | $1,722,000 | -32.2% | 61,864 | 0.0% | 0.01% | -35.7% |
| Q3 2021 | $2,541,000 | +9.1% | 61,864 | +50.4% | 0.01% | 0.0% |
| Q2 2021 | $2,330,000 | +38.9% | 41,134 | +3.0% | 0.01% | +27.3% |
| Q1 2021 | $1,678,000 | +37.2% | 39,952 | +129.2% | 0.01% | +37.5% |
| Q4 2020 | $1,223,000 | +147.6% | 17,429 | -1.1% | 0.01% | +100.0% |
| Q3 2020 | $494,000 | +4016.7% | 17,622 | +4327.6% | 0.00% | – |
| Q2 2020 | $12,000 | – | 398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |